Sun Pharma pays US$30mn for 16.7% stake in US-based Lyndra Therapeutics
India’s Sun Pharmaceuticals Ltd said on Monday that it has entered into agreement to acquire a 16.7 per cent stake in US company Lyndra Therapeutics Inc for $30 million.
Stay updated with breaking news from Langer Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India’s Sun Pharmaceuticals Ltd said on Monday that it has entered into agreement to acquire a 16.7 per cent stake in US company Lyndra Therapeutics Inc for $30 million.
India's Sun Pharmaceuticals Ltd said on Monday that it has entered into agreement to acquire a 16.7 per cent stake in US company Lyndra Therapeutics Inc for $30 million.Mumbai, Dec 18 (IANS) India’s Sun Pharmaceuticals Ltd said on Monday ...
The US company had a turnover of $10.7 million in 2022.
In mice and human cell cultures, MIT researchers showed that lipid nanoparticles can deliver a potential RNA therapy for inflammation in the brain, a prominent symptom in Alzheimer’s disease.
<p>In mice and human cell cultures, MIT researchers showed that novel nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s disease</p>